Hall Capital Management Reduces Stake in Thermo Fisher Scientific

NodeGuardian · 2026-03-12T01:51:49+00:00

Hall Capital Management significantly cut its stake in Thermo Fisher Scientific by over 67% in Q3 2026, selling 3,297 shares and keeping 1,592, reflecting a portfolio rebalancing and shifts in investment strategies in the medical research sector.

NodeGuardian

2026-03-12 01:51:49

Abstract generation in progress

Hall Capital Management Co. Inc. significantly reduced its stake in Thermo Fisher Scientific (NYSE:TMO) by over 67% in the third quarter of 2026, selling 3,297 shares and retaining 1,592 shares valued at $772,000. The firm cited portfolio rebalancing as the reason for this decision, highlighting a notable shift in institutional investment strategy within the medical research industry. This move provides insight into investor sentiment towards Thermo Fisher Scientific and broader market trends.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes